Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Cash (2016 - 2025)

Historic Change in Cash for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$890536.0.

  • Cumberland Pharmaceuticals' Change in Cash fell 79406.12% to -$890536.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 11740.65%. This contributed to the annual value of -$357440.0 for FY2024, which is 7511.46% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Change in Cash stood at -$890536.0, which was down 79406.12% from $978868.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Change in Cash ranged from a high of $1.9 million in Q2 2023 and a low of -$9.8 million during Q1 2022
  • In the last 5 years, Cumberland Pharmaceuticals' Change in Cash had a median value of $216432.0 in 2022 and averaged -$503002.7.
  • The largest annual percentage gain for Cumberland Pharmaceuticals' Change in Cash in the last 5 years was 66690.44% (2022), contrasted with its biggest fall of 587903.91% (2022).
  • Cumberland Pharmaceuticals' Change in Cash (Quarter) stood at $1.2 million in 2021, then crashed by 81.93% to $216432.0 in 2022, then crashed by 186.1% to -$186341.0 in 2023, then skyrocketed by 368.02% to $499430.0 in 2024, then crashed by 278.31% to -$890536.0 in 2025.
  • Its last three reported values are -$890536.0 in Q3 2025, $978868.0 for Q2 2025, and -$2.9 million during Q1 2025.